Breast cancer resistance protein (BCRP/ABCG2) does not confer resistance to gemtuzumab ozogamicin and calicheamicin-gamma1 in acute myeloid leukemia cells

Leukemia. 2004 Nov;18(11):1914-7. doi: 10.1038/sj.leu.2403461.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily G, Member 2
  • ATP-Binding Cassette Transporters / metabolism*
  • Acute Disease
  • Aminoglycosides / therapeutic use*
  • Antibiotics, Antineoplastic / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Drug Resistance, Multiple
  • Drug Resistance, Neoplasm
  • Enediynes
  • Gemtuzumab
  • Humans
  • Immunotoxins / therapeutic use*
  • Leukemia, Myeloid / drug therapy*
  • Methotrexate
  • Neoplasm Proteins / metabolism*
  • Tumor Cells, Cultured

Substances

  • ABCG2 protein, human
  • ATP Binding Cassette Transporter, Subfamily G, Member 2
  • ATP-Binding Cassette Transporters
  • Aminoglycosides
  • Antibiotics, Antineoplastic
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Enediynes
  • Immunotoxins
  • Neoplasm Proteins
  • calicheamicin gamma(1)I
  • Gemtuzumab
  • Methotrexate